SAREPTA THERAPEUTICS, INC.: operating cash flow

What this measure means

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Exact concept: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2009-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• SAREPTA THERAPEUTICS, INC.: total assets
• SAREPTA THERAPEUTICS, INC.: total liabilities
• SAREPTA THERAPEUTICS, INC.: stockholders equity
• SAREPTA THERAPEUTICS, INC.: cash and cash equivalents
• SAREPTA THERAPEUTICS, INC.: net income or loss
• SAREPTA THERAPEUTICS, INC.: capital expenditure payments
• SAREPTA THERAPEUTICS, INC.: revenue
• SAREPTA THERAPEUTICS, INC.: contract revenue excluding tax
• SAREPTA THERAPEUTICS, INC.: financing cash flow
• SAREPTA THERAPEUTICS, INC.: investing cash flow
• SAREPTA THERAPEUTICS, INC.: retained earnings or deficit
• SAREPTA THERAPEUTICS, INC.: basic weighted-average shares
• SAREPTA THERAPEUTICS, INC.: diluted weighted-average shares
• SAREPTA THERAPEUTICS, INC.: basic earnings per share
• SAREPTA THERAPEUTICS, INC.: diluted earnings per share
• SAREPTA THERAPEUTICS, INC.: income tax expense or benefit
• SAREPTA THERAPEUTICS, INC.: net property, plant and equipment
• SAREPTA THERAPEUTICS, INC.: share-based compensation expense
• SAREPTA THERAPEUTICS, INC.: operating income or loss
• SAREPTA THERAPEUTICS, INC.: current assets
• SAREPTA THERAPEUTICS, INC.: interest expense
• SAREPTA THERAPEUTICS, INC.: current liabilities
• SAREPTA THERAPEUTICS, INC.: current accounts payable
• SAREPTA THERAPEUTICS, INC.: net finite-lived intangible assets
• SAREPTA THERAPEUTICS, INC.: net current accounts receivable
• SAREPTA THERAPEUTICS, INC.: common-stock repurchase payments
• SAREPTA THERAPEUTICS, INC.: operating expenses
• SAREPTA THERAPEUTICS, INC.: net inventory
• SAREPTA THERAPEUTICS, INC.: selling, general and administrative expense
• SAREPTA THERAPEUTICS, INC.: research and development expense

Inspect the source

Entity

SAREPTA THERAPEUTICS, INC. / CIK 0000873303

Captured

2026-09-20T05:00:35.473Z

SEC response SHA-256

73fbffcbdadfe28b857d7fca50ab4aac61e15003102807aade5f366cc35bb6b9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000873303.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))